Contact us

LinkedIn
Loading...
News & events2020-02-03T16:08:20+00:00

Announcements

6th
April
2020
Ligand Provides a Corporate Update and Announces May 6th as the Date for First Quarter Earnings Call
12th
February
2020
Success Milestone in Oncology Collaboration with Servier
19th
September
2019
Interview in Drug Target Review with James Murray, Research Director at Vernalis
12th
June
2019
Ligand Subsidiary Vernalis and PhoreMost Limited Announce Drug Discovery Collaboration for Novel Oncology Target
17th
May
2019
Ligand Licenses VER250840 to Cumulus Oncology
17th
December
2018
Success Milestone in Collaboration with Asahi Kasei Pharma
13th
November
2018
Successes in Daiichi Sankyo Collaboration
10th
October
2018
Ligand anounces the close of its acquisition of Vernalis
13th
December
2017
Vernalis plc enters into research collaboration with Daiichi Sankyo
6th
December
2017
Vernalis and Servier Achieve Research Milestone in Third Oncology Collaboration
12th
September
2017
Results Announcement for the year ended 30 June 2017
18th
July
2017
Year-End Trading Update and Notice of Full Year Results

Filter

Upcoming conferences

Update

May 1, 2020

Watch this space for upcoming webinars and details of future [...]

Past conferences

Biophysics in Drug Discovery 2019- 7th NovAliX Conference

November 13, 2019 - November 15, 2019

Speaker: Ben Davis

Fragment-Based Drug Discovery Down Under Conference 2019

November 12, 2019 - November 15, 2019

Speaker: Alba Macias

BIO-Europe -25th Annual International Partnering Conference

November 11, 2019 - November 13, 2019

Attendees: Romain Lalandes and Mike Wood

NMR in Drug Discovery

October 31, 2019

Speaker: Ben Davis

International Symposium on Diffraction Structural Biology 2019

October 17, 2019 - October 20, 2019

Speaker: Rod Hubbard

Fragment Based Drug Discovery: Case Histories and Experiences of Combining Orthogonal Methods

September 10, 2019

Speaker: Ben Davis

© 2019–2020 Vernalis (R&D) Limited. All Rights Reserved. Designed by Douglass Digital
This website uses cookies and third party services. Read our Privacy Policy Ok